Ignite Creation Date:
2025-12-24 @ 10:04 PM
Ignite Modification Date:
2026-02-22 @ 3:56 PM
Study NCT ID:
NCT00789035
Status:
COMPLETED
Last Update Posted:
2014-06-18
First Post:
2008-10-13
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
12 Weeks Treatment With 3 Different Doses of BI 10773 in Type 2 Diabetic Patients
Sponsor:
Boehringer Ingelheim
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
1245.9
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
None
Responsible Party Affiliation:
Old Name:
Boehringer Ingelheim, Study Chair
Old Organization:
Boehringer Ingelheim